1. Home
  2. BOLT vs OSRH Comparison

BOLT vs OSRH Comparison

Compare BOLT & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • OSRH
  • Stock Information
  • Founded
  • BOLT 2015
  • OSRH N/A
  • Country
  • BOLT United States
  • OSRH United States
  • Employees
  • BOLT N/A
  • OSRH N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • OSRH
  • Sector
  • BOLT Health Care
  • OSRH
  • Exchange
  • BOLT Nasdaq
  • OSRH Nasdaq
  • Market Cap
  • BOLT 16.8M
  • OSRH 19.0M
  • IPO Year
  • BOLT 2021
  • OSRH N/A
  • Fundamental
  • Price
  • BOLT $5.50
  • OSRH $0.56
  • Analyst Decision
  • BOLT Buy
  • OSRH
  • Analyst Count
  • BOLT 3
  • OSRH 0
  • Target Price
  • BOLT $50.00
  • OSRH N/A
  • AVG Volume (30 Days)
  • BOLT 16.5K
  • OSRH 1.3M
  • Earning Date
  • BOLT 08-19-2025
  • OSRH 08-24-2025
  • Dividend Yield
  • BOLT N/A
  • OSRH N/A
  • EPS Growth
  • BOLT N/A
  • OSRH N/A
  • EPS
  • BOLT N/A
  • OSRH N/A
  • Revenue
  • BOLT $3,638,000.00
  • OSRH N/A
  • Revenue This Year
  • BOLT N/A
  • OSRH N/A
  • Revenue Next Year
  • BOLT $13.62
  • OSRH N/A
  • P/E Ratio
  • BOLT N/A
  • OSRH N/A
  • Revenue Growth
  • BOLT N/A
  • OSRH N/A
  • 52 Week Low
  • BOLT $5.20
  • OSRH $0.56
  • 52 Week High
  • BOLT $14.36
  • OSRH $12.54
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 40.87
  • OSRH N/A
  • Support Level
  • BOLT $5.30
  • OSRH N/A
  • Resistance Level
  • BOLT $5.94
  • OSRH N/A
  • Average True Range (ATR)
  • BOLT 0.31
  • OSRH 0.00
  • MACD
  • BOLT -0.04
  • OSRH 0.00
  • Stochastic Oscillator
  • BOLT 13.34
  • OSRH 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About OSRH OSR Holdings Inc. Common Stock

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: